Eptifibatide
Top View
- The Evidence for Its Role in the Management of Acute Coronary Syndromes
- Annex I Summary of Product Characteristics
- Antithrombotic Reversal – Adult – Inpatient Clinical Practice Guideline
- Integrilin, INN-Eptifibatide
- Non-ST-Elevation Acute Coronary Syndromes AHA/ACC 2014
- Newer Anticoagulants/ Antiplatelets and Patient Teaching
- An" Arterial Thrombosis-On-A-Chip" Microfluidic Device for Investigating
- Antithrombotic Therapy in Patients with Acute Coronary Syndromes
- Statistics on Medicines Consumption 2009
- Recent Progress and Market Analysis of Anticoagulant Drugs
- Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery After Coronary Stent Implantation: a Real-World Bridging Protocol Experience
- Cangrelor: Safe and Effective for Left Ventricular Assist Device Thrombosis
- Use of Continuous Infusions of Eptifibatide and Cangrelor in Large Vessel Occlusion Acute Ischemic Stroke After Emergent Carotid Artery Stenting
- Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing
- Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
- Combination of Thrombolysis and Glycoprotein Iib/Iiia Inhibition in Chronic Peripheral Thrombosis: a Case Report
- Release of Soluble CD40L from Platelets Is Regulated by Glycoprotein Iib/Iiia and Actin Polymerization Mark I
- A Clinically Efficacious Case of Eptifibatide Administration in Achieving Vascular Recanalization